50 results

Vascepa – which will be sold as Vazkepa in Europe – reduces harmful blood fats called triglycerides in patients at risk of potentially fatal heart attack or stroke.

Amarin, the Irish biotech that developed a cardiovascular drug out of refined fish oil, is gearing up for a launch in Europe. It will be a further va(...)

Shares in cardiovascular drugmaker Amarin slumped over 70% last night as the company lost a key patent case in Nevada.

Shares in Irish heart drug company Amarin slumped more than 70 per cent last night as the company lost a key court case in Nevada over the patents of (...)

Irish drug company Amarin says sales from Vascepa, its one cardiovascular drug for 2019, will be at or above the upper end of its previous guidance

Irish drug company Amarin says sales from its one cardiovascular drug for 2019 will be at or above the upper end of its previous guidance – indicating(...)

Irish heart drug company Amarin’s Vascepa is approved for widespread use in the US, Canada, the United Arab Emirates and Lebanon.

Irish heart drug company Amarin has secured approval from Canadian authorities to sell its one drug in that market. The Canadian green light comes ju(...)

Noel and Valerie Moran walked away with a €266 million payout for Prepaid Financial Service. Photograph: Alan Betson

It was a year of extremes in the corporate world – financial reward and glory for some; the end of the road for others. And 2019 also saw a cast of fi(...)

Amarin’s Vascepa has been found to reduce the risk of cardiovascular events in high-risk patients already being treated with statins.

Amarin, the US-based Irish drug development business, said the European Medicines Agency has accepted an application to licence its cardiovascular dru(...)

Amarin’s John Thero:  “Breakthroughs in preventative cardiovascular care are rare and greatly needed.” Photograph: Cyril Byrne

John Thero, the president and chief executive of fish-oil drug specialist Amarin, has been awarded the EY Entrepreneur of the Year award in the US for(...)

Amarin: will Vascepa be prescribed as a preventative therapy or one used only when evidence of disease is found?

It would be churlish to try to put a dampener on the Amarin team after a Food and Drug Administration advisory panel voted 16-0 to back a dramatic inc(...)

US medicines regulator, the Food and Drug Administration, has cleared a major increase in the patients that can access a heart drug from small Irish pharma Amarin.

Shares in Amarin jumped on news that it had won the backing of an FDA advisory panel to sell its heart drug Vascepa to a wider group of patients. The(...)

A major push towards legalisation here may come from US and Canadian cannabis corporations who view Ireland as a jump-off point into the EU market. Photograph:  Rungroj Yongrit/EPA

It is inevitable that cannabis will be legalised in Ireland in the coming years. It may take five years or even longer for the prohibition to be fully(...)

  • 1
  • 2
  • 3
  • 4
  • 5
  • Next
  • Last »